Abstract:Numerous studies have proved that cell-nonautonomous regulation of neoplastic cells is a distinctive and essential characteristic of tumorigenesis. Two way communications between the tumor and the stroma, or within the tumor significantly influence disease progression and modify treatment responses. In the tumor microenvironment (TME), malignant cells utilize paracrine signaling initiated by adjacent stromal cells to acquire resistance against multiple types of anticancer therapies, wherein extracellular vesicles (EVs) substantially promote such events. EVs are nanoscaled particles enclosed by phospholipid bilayers, and can mediate intercellular communications between cancerous cells and the adjacent microenvironment to accelerate pathological proceeding. Here we review the most recent studies of EV biology and focus on key cell lineages of the TME and their EV cargoes that are biologically active and responsible for cancer resistance, including proteins, RNAs, and other potentially essential components. Since EVs are emerging as novel but critical elements in establishing and maintaining hallmarks of human cancer, timely and insightful understanding of their molecular properties and functional mechanisms would pave the road for clinical diagnosis, prognosis, and effective targeting in the global landscape of precision medicine. Further, we address the potential of EVs as promising biomarkers in cancer clinics and summarize the technical improvements in EV preparation, analysis, and imaging. We highlight the practical issues that should be exercised with caution to guide the development of targeting agents and therapeutic methodologies to minimize cancer resistance driven by EVs, thereby allowing to effectively control the early steps of disease exacerbation.

Roles of M1 Macrophages and Their Extracellular Vesicles in Cancer Therapy

Tumor Cell-derived Extracellular Vesicles in Modulating Phenotypes and Immune Functions of Macrophages: Mechanisms and Therapeutic Applications.

Small Extracellular Vesicles-Mediated Cellular Interactions Between Tumor Cells and Tumor-Associated Macrophages: Implication for Immunotherapy.

Extracellular Vesicles Derived from Macrophages: Current Applications and Prospects in Tumors

Exosomes: A Potential Therapeutic Tool Targeting Communications Between Tumor Cells and Macrophages.

Tumor-derived extracellular vesicles regulate macrophage polarization: role and therapeutic perspectives

Engineering extracellular vesicles derived from macrophages for tumor therapy: a review

Exosomal Micrornas Shuttling Between Tumor Cells and Macrophages: Cellular Interactions and Novel Therapeutic Strategies

The Roles of Extracellular Vesicles in Malignant Melanoma

Crosstalk between extracellular vesicles and tumor-associated macrophage in the tumor microenvironment

Extracellular vesicles remodel tumor environment for cancer immunotherapy

Tumor-Derived Extracellular Vesicles: A Means of Co-opting Macrophage Polarization in the Tumor Microenvironment

Macrophage-derived Extracellular Vesicles: Diverse Mediators of Pathology and Therapeutics in Multiple Diseases

Extracellular vesicles in the tumor microenvironment: old stories, but new tales

Tumor-Derived Extracellular Vesicles Regulate Cancer Progression in the Tumor Microenvironment

Role of Extracellular Vesicles in Tumour Microenvironment

Engineering Macrophages for Cancer Immunotherapy and Drug Delivery

Extracellular vesicles in the tumor microenvironment: Therapeutic resistance, clinical biomarkers, and targeting strategies

The roles of small extracellular vesicles in cancer and immune regulation and translational potential in cancer therapy

Tumor-derived Extracellular Vesicles: Regulators of Tumor Microenvironment and the Enlightenment in Tumor Therapy

Extracellular Vesicles in Cancer Therapy: Roles, Potential Application, and Challenges